Cargando…
The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation
Immunomodulation of mast cell (MC) activity is warranted in allergic and inflammatory diseases where MCs have a central role in pathogenesis. Targeting Siglec-8, an inhibitory receptor on MCs and eosinophils, has shown promising activity in preclinical and clinical studies. While the intracellular p...
Autores principales: | Korver, Wouter, Wong, Alan, Gebremeskel, Simon, Negri, Gian Luca, Schanin, Julia, Chang, Katherine, Leung, John, Benet, Zachary, Luu, Thuy, Brock, Emily C., Luehrsen, Kenneth, Xu, Alan, Youngblood, Bradford A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837033/ https://www.ncbi.nlm.nih.gov/pubmed/35154156 http://dx.doi.org/10.3389/fimmu.2022.833728 |
Ejemplares similares
-
Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells
por: Schanin, Julia, et al.
Publicado: (2022) -
Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
por: Gebremeskel, Simon, et al.
Publicado: (2021) -
Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
por: Robida, Piper A., et al.
Publicado: (2022) -
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
por: Schanin, Julia, et al.
Publicado: (2020) -
FcεRI: A Master Regulator of Mast Cell Functions
por: Nagata, Yuka, et al.
Publicado: (2022)